I believe the initial study is for safety and tolerance with MRI...

I believe the initial study is for safety and tolerance with MRI scan before removal of the lymph nodes. The lymph nodes are then sent to the US for testing under the mag sense scanner. After that will be a pivotal study of around 200 to 300 patients that will be testing for efficacy.
I am very much in the corner of many others that this company will be in the dollars in 5-10 years. I will be holding out for the $10+ range. Initial breast cancer study. Pivotal study. Commercialisation. Further studies for lung cancer prostate ovarian and brain cancer.
This is not a share to sweat the day to day.  You will look back in 5+ years and kick yourself you sold that share at $.20 when you're looking at $10.